This company seems to have been delisted
Reason: Acquired by Novo Holdings
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Reason: Acquired by Novo Holdings
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Catalent
CTLT
£49.07
Share price
0.00%
Change (1 day)
10.98%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
Catalent (CTLT) - Total assets
Total assets on the balance sheet as of September 2024 : £7.50 Billion
According to Catalent's latest financial reports the company's total assets are £7.50 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Catalent - Total assets on balance sheet (from 2013 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-06-30 | £8.54 B | -1.37% |
| 2022-06-30 | £8.66 B | 31.58% |
| 2021-06-30 | £6.58 B | 4.2% |
| 2020-06-30 | £6.31 B | 29.69% |
| 2019-06-30 | £4.87 B | 42% |
| 2018-06-30 | £3.43 B | 29.21% |
| 2017-06-30 | £2.65 B | 15.65% |
| 2016-06-30 | £2.29 B | 15.07% |
| 2015-06-30 | £1.99 B | 9.96% |
| 2014-06-30 | £1.81 B | -6.43% |
| 2013-06-30 | £1.93 B | -3.1% |
| 2012-06-30 | £2.00 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 | £1.05 B | -85.91% | 🇺🇸 USA |
 | £0.29 B | -96.13% | 🇺🇸 USA |
 | £9.28 B | 23.74% | 🇮🇪 Ireland |
 | £0.30 B | -95.95% | 🇺🇸 USA |